Law360 (November 30, 2010, 6:39 PM EST) -- Bristol-Myers Squibb Co. is under fire from an AIDS nonprofit alleging the pharmaceutical giant breached an agreement by overcharging for drugs that should have been discounted as part of the health care overhaul.
The complaint, filed last Wednesday in the U.S. District Court for the Central District of California, claims that Bristol-Myers failed to promptly lower drug prices for nonprofit and governmental medical providers as required by the new health care law, overcharging the AIDS Healthcare Foundation by more than $124,000.
The Patient Protection and Affordable...
AIDS Nonprofit Says BMS Overcharged For Drugs
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
